NCT07002216
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07002216
Title BrECADD Therapy in Stage 2 B-IV Hodgkin Lymphoma (BrECADD)
Acronym BrECADD
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Miami
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Miami RECRUITING Miami Florida 33146 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field